News

Being an outpatient psychiatrist is a lot like being married. Things go along, the same-old, for long periods. But then there's a moment. Today, with Leslie, I remember why I love my work.

Several new findings have emerged, one of which comes very close to providing a noninvasive “lab test” for bipolar disorder.

When even listening fails, presence is all that’s left.

This is the story of Peter. I feel chosen to have gotten to know him and to have the memory of what such an experience has carved into me.

The public has questioned the wisdom of a judge to release a psychiatric inpatient, but not just any patient. Enter our metaphoric haunted house at your own risk.

“Election addiction disorder, undifferentiated, DSM-5A-177.6x” is characterized by an overwhelming need to watch anything and everything related to the current race for the White House, no matter how microscopic. Clinical details and prognosis are examined here.

The supposed “epidemic” of mental illness turns out to be mostly a myth in the US adult population, 2000-2015.

Which symptoms might indicate both schizophrenia and a mood disorder? Test your skills in this quiz.

What an exciting time to be involved in understanding and providing care for people with schizophrenia spectrum disorders!

Psychiatrists who treat patients with psychosis in institutional, community, and crisis settings provide evaluations and medication management, but rarely consider psychotherapeutic interventions. However, such interventions can be critical in recovery.

Culture-the way people make meaning and live their lives in particular social worlds-matters in psychosis. The authors explore how a patient's cultural background should influence the way clinicians think about treatment and care.

Are you up-to-date on the treatment of psychotic depression? How about the clinical implications of brain GABA levels? Take this quiz and find out.

The authors discuss the clinical implications of the changes in the DSM-5 section on schizophrenia spectrum and other psychotic disorders.

A review of the distinction between depressive and psychotic symptom domains, current knowledge about the etiology and neurobiology of depression and psychosis, and how this knowledge can inform the treatment of patients with features of both.

Will novel treatments from around the world be treats or tricks? Whatever they turn out to be, they are as fascinating and varied as Halloween costumes.

It is not unusual for patients to seek consultation with questions about their sexuality. This article provides useful definitions and clinical examples for therapists who wish to address these patient concerns.

Meet "Gary," whose case provides an introduction to the value of systems-based practice.

I started promoting pharmacogenetic tests in the 1990s-before they were fashionable-and now, after going through the 3 phases of pharmacogenetic testing (fear, failure, and hype), I am embarrassed.

Is St. John’s wort (SJW; Hypericum perforatum) an appropriate treatment option for patients with MDD? What advice should be given to patients who inquire about it?

The authors focus on the psychiatric management of transplant recipients and the evaluation and care of living organ donors.

What does mandated electronic prescribing have to do with that old show, Twilight Zone?

Almost everyone can benefit from psychotherapy at some point in their lives.

The assessment, diagnosis, and treatment of conditions in which persistent pain is a feature despite lack of evidence of a pathological cause are reviewed in this article.

The next phase of HIPAA compliance audits has arrived. Clinicians who are HIPAA-covered entities-or business associates-would be well served to prepare now.

I hope readers look seriously at what the Presidential candidates have to say-or if they say anything at all-about addressing the current and increasing disaster in the mental health system before casting their votes.

Is it time again for greater unification of neurology and psychiatry?

He wrote that he didn’t know what to say to comfort us, so he decided to describe the view from his rented room near Sydney...

“Googling” a patient does not seem much different from the old-fashioned obtaining of collateral information, but the ramifications may be far more than you bargain for.

It’s not health care expenses that are driving up costs.

Why is there so little clamor for a drug that prevents neurodegeneration, carries very low risk, and is unlikely to produce significant side effects?